NCT06593470 (MINDS-UP) is a NA clinical trial of MINDS-UP in Substance Use, sponsored by New York State Psychiatric Institute.

Who is sponsoring NCT06593470?

NCT06593470 is sponsored by New York State Psychiatric Institute.

What drugs are being tested in NCT06593470?

Interventions in NCT06593470: MINDS-UP, Prevention Plus Wellness, fMRI.

What condition does NCT06593470 study?

NCT06593470 studies Substance Use.

Is NCT06593470 still recruiting?

NCT06593470 is currently not yet recruiting. Last updated 19 August 2025.

Last reviewed 2025-08-19 · How we verify

NCT06593470: MINDS-UP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mindfulness-Based Substance Use Prevention (MINDS-UP)

Not yet recruiting NA Last updated 19 August 2025

What this trial tests

NA trial testing MINDS-UP in Substance Use in 45 participants. Not yet recruiting.

Timeline

1 March 2026

Primary endpoint
1 January 2028

1 January 2028

Quick facts

Lead sponsor	New York State Psychiatric Institute
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	45
Start date	1 March 2026
Primary completion	1 January 2028
Estimated completion	1 January 2028

Drugs / interventions tested

MINDS-UP
Prevention Plus Wellness
fMRI — full drug profile →

Conditions studied

Substance Use — all drugs for Substance Use →

Sponsor

New York State Psychiatric Institute

Who can join

Adults 10 to 14, any sex, with Substance Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test the feasibility, behavioral/neural mechanisms, and preliminary efficacy of "MINDfulness-based Substance Use Prevention Program," or "MINDS-UP", a novel substance use prevention meditation intervention for children and adolescents between the ages of 10 and 14. The main questions it aims to answer are: 1. Is MINDS-UP feasible and what is its preliminary efficacy? 2. Are MRI protocol and procedures feasible? An additional exploratory question is: Are there neural and psychopathological mechanisms through which MINDS-UP might work? Researchers will compare Sport - Prevention Plus Wellness (PPW) (an evidence based substance use prevention program) to Sport - Prevention Plus Wellness + MINDS-UP to examine the preliminary efficacy of MINDS-UP. Participants will * take assessment #1 * have 2 MRIs and take MINDS-UP, just take MINDS-UP or have a delayed start * take assessment #2 * take PPW, a single remote and research assistant-delivered 45-minute session * take assessment #3 * take assessment #4

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Substance Use

Currently open trials in the same condition.

NCT07075081 — Gii'Igoshimong: Sitting With Your First Family · Phase 2 · recruiting
NCT05743699 — Adaptation and Evaluation of Bright Horizons · NA · recruiting
NCT07509853 — Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engag · NA · recruiting
NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
NCT07512869 — Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Impl · recruiting

Other New York State Psychiatric Institute trials

Trials by the same sponsor.

NCT05416658 — Shared Decision Making for Antipsychotic Medications · NA · not yet recruiting
NCT07423546 — A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia · Phase 1, PHASE2 · not yet recruiting
NCT05339256 — Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual · Phase 2 · not yet recruiting
NCT05563948 — Repeated Administration of Cannabis Varying in THC and CBD · Phase 2 · suspended
NCT06977308 — A Multimodal Imaging Study of Dopamine in Early Psychosis · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06593470 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by New York State Psychiatric Institute
Last refreshed: 19 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06593470.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing